Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:LEGN News 5 January 2026 - 7 January 2026

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

New York, January 7, 2026, 12:32 (EST) — Regular session Shares of Legend Biotech Corp rose 7.4% to $22.53 in midday trading on Wednesday after Oppenheimer initiated coverage with an “Outperform” rating and set a $75 price target, according to MarketBeat. StreetInsider said Oppenheimer analyst Trevor Allred authored the initiation note. MarketBeat Why it matters now: Legend’s stock has been…
7 January 2026
·····
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

New York, January 5, 2026, 15:53 EST — Regular session Legend Biotech Corp (LEGN) shares fell 4.7% to $20.49 on Monday, after touching $20.29 — a fresh 52-week low — in afternoon trading. The stock is about 55% below its 52-week high of $45.30. SoFi Money rotated into energy and bank stocks on Monday, lifting Wall Street’s main indexes, after…
5 January 2026
····

Stock Market Today

  • Undiscovered Small-Cap Stocks in Global Markets for January 2026
    January 29, 2026, 4:52 AM EST. As global markets face economic uncertainties, investors focus on small-cap stocks showing resilience and growth potential. Key players include Saha-Union, Synergy Innovation, and Shenzhen Zhongheng Huafa, all with strong revenue and earnings growth. Limin Group Co., Ltd., a Chinese agricultural chemicals firm, posted a 360% earnings surge and trades below its fair value, signaling an undervalued opportunity. Meanwhile, Jiangyin Electrical Alloy, specializing in copper products, reflects mixed profitability amid market fluctuations. These stocks demonstrate solid fundamentals with low to moderate debt levels, positioning them as potential winners despite broader market volatility. Investors seeking growth within small caps should monitor these firms as economic conditions evolve.
Go toTop